fluocinolone acetonide has been researched along with Inflammation in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (44.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Buhl, L; Kern, C; Thurau, S | 1 |
| Chang, PY | 1 |
| Eichenbaum, DA; Hariprasad, SM; Kiernan, DF; Kolomeyer, AM; Suñer, IJ | 1 |
| Christoforidis, J; Jiang, A; Joshi, M; Wang, J | 1 |
| Boero, S; Rossi, GA; Silvestri, M; Ullmann, N | 1 |
| Hebson, CB; Srivastava, SK | 1 |
| Kim, SJ; Park, UC; Yu, HG | 1 |
| Glybina, IV; Guru, BR; Iezzi, R; Kannan, RM; Kennedy, A; Mishra, MK | 1 |
| Christodoulopoulos, P; Danda, R; Gotfried, M; Hamid, Q; Hauber, HP; Newman, K; Servi, RJ | 1 |
| ALIADIAZ, M; GIJON, JR; RODRIGUEZMURCIA, C | 1 |
| HEITE, HJ; KALKOFF, KW; KOHLER, H | 1 |
| Berghaus, LJ; Berghaus, RD; Byerly, JR; Decile, KC; Gershwin, LJ; Hyde, DM; Reinero, CR; Schelegle, ES; Walby, WE | 1 |
| Lightman, S; McCluskey, P; Sivaprasad, S | 1 |
| Morris, RJ | 1 |
| Ballaron, SJ; De Young, LM; Puhvel, SM; Spires, DA; Young, JM | 1 |
| Celasco, G; Galletti, F; Gardi, R | 1 |
| Martin, RJ | 1 |
| Bianchetti, A; Netti, C; Pecile, A | 1 |
| Banfi, S; Carpi, C; Cornelli, U | 1 |
| Avery, GS; Brogden, RN; Speight, TM | 1 |
| De Ruggieri, P; Frova, C; Maistrello, I; Rigamonti, G | 1 |
| Bocian, E; Dziuk, E; Merta, A | 1 |
| Greaves, MW; McDonald-Gibson, W | 1 |
| Ishikawa, H; Mori, Y; Tsurufuji, S | 1 |
4 review(s) available for fluocinolone acetonide and Inflammation
| Article | Year |
|---|---|
Drug delivery implants in the treatment of vitreous inflammation.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Biocompatible Materials; Clinical Trials as Topic; Dexamethasone; Drug Delivery Systems; Eye; Fluocinolone Acetonide; Ganciclovir; Humans; Inflammation; Particle Size; Polymers; Prostheses and Implants; Ranibizumab; Triamcinolone Acetonide; Vitreous Body | 2013 |
Intravitreal steroids in the management of macular oedema.
Topics: Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Therapeutic significance of distal airway inflammation in asthma.
Topics: Aerosol Propellants; Anti-Inflammatory Agents; Asthma; Bronchi; Fluocinolone Acetonide; Humans; Hydrocarbons, Fluorinated; Inflammation | 2002 |
Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
Topics: Administration, Topical; Croton Oil; Drug Hypersensitivity; Eczema; Fluocinolone Acetonide; Humans; Inflammation; Pharmaceutical Vehicles; Propylene Glycols; Psoriasis; Radiation Injuries; Skin Diseases; Steroids, Fluorinated; Ultraviolet Rays; Vasoconstrictor Agents | 1974 |
1 trial(s) available for fluocinolone acetonide and Inflammation
| Article | Year |
|---|---|
Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma.
Topics: Airway Resistance; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Cat Diseases; Cats; Cross-Over Studies; Cyproheptadine; Female; Fluocinolone Acetonide; Immunoglobulin A; Immunoglobulin G; Indoles; Inflammation; Male; Phenylcarbamates; Prednisone; Respiratory Therapy; Sulfonamides; Tosyl Compounds | 2005 |
20 other study(ies) available for fluocinolone acetonide and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study.
Topics: Cataract; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Uveitis; Uveitis, Posterior | 2023 |
Use of fluocinolone acetonide intravitreal implant to manage chronic panuveitis for long-term inflammatory control without interfering with systemic immunity.
Topics: Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Male; Panuveitis; Uveitis, Posterior; Vitreous Body | 2022 |
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Macular Edema | 2023 |
Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation.
Topics: Anti-Inflammatory Agents; Bronchi; Cell Adhesion; Cell Line; Dose-Response Relationship, Drug; Eosinophils; Epithelial Cells; Fluocinolone Acetonide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-5; Tumor Necrosis Factor-alpha | 2010 |
A functional, nonfunctioning Retisert implant.
Topics: Aged; Anti-Inflammatory Agents; Device Removal; Drug Implants; Equipment Failure; Eye Diseases; Female; Fluocinolone Acetonide; Humans; Inflammation; Macular Edema; Retreatment; Treatment Outcome; Vitreous Body | 2011 |
Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Antiviral Agents; Behcet Syndrome; Corneal Edema; Cytomegalovirus Infections; Drug Implants; Endothelium, Corneal; Fluocinolone Acetonide; Ganciclovir; Humans; Inflammation; Male; Uveitis; Valganciclovir; Vision Disorders | 2011 |
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration.
Topics: Animals; Anti-Inflammatory Agents; Dendrimers; Electroretinography; Fluocinolone Acetonide; Inflammation; Intravitreal Injections; Neuroimmunomodulation; Rats; Retinal Degeneration | 2012 |
Effect of HFA-flunisolide on peripheral lung inflammation in asthma.
Topics: Adult; Anti-Asthmatic Agents; Asthma; Chemokine CCL11; Chemokines, CC; Eosinophils; Female; Fluocinolone Acetonide; Humans; Hydrocarbons, Fluorinated; Inflammation; Interleukin-5; Lung; Male; RNA, Messenger | 2003 |
[PHARMACOLOGY OF SYNTHETIC CORTICAL STEROIDS OF ANTIINFLAMMATORY ACTION].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betamethasone; Cortisone; Dexamethasone; Fluocinolone Acetonide; Foreign Bodies; Granuloma; Hydrocortisone; Inflammation; Pharmacology; Prednisolone; Rats; Research; Triamcinolone | 1963 |
[ON THE ANTI-INFLAMMATORY EFFECT OF DIFFERENT STEROID OINTMENTS ON THE HUMAN SKIN DETERMINED ON PYREXAL ERYTHEMA].
Topics: Anti-Inflammatory Agents; Biomedical Research; Erythema; Fluocinolone Acetonide; Humans; Hydrocortisone; Inflammation; Ointments; Pharmacology; Skin; Steroids; Triamcinolone | 1964 |
Stem cells in the hair follicle and interfollicular epidermis of mice following topical application of fluocinolone acetonide.
Topics: Animals; Anti-Inflammatory Agents; Cell Nucleus; Cell Proliferation; Epidermal Cells; Epidermis; Fluocinolone Acetonide; Hair Follicle; Inflammation; Keratinocytes; Mice; Receptors, Glucocorticoid; Stem Cells; Time Factors | 2007 |
Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne.
Topics: Acne Vulgaris; Animals; Benzoyl Peroxide; Disease Models, Animal; Erythromycin; Female; Fluocinolone Acetonide; Inflammation; Injections, Intradermal; Naproxen; Propionibacterium acnes; Pyrazoles; Rats; Rats, Inbred Strains; Tetracycline; Tretinoin | 1984 |
Biological properties of a new non-fluorinated topical antiinflammatory steroid.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone Valerate; Female; Fluocinolone Acetonide; Humans; Inflammation; Mitosis; Prednisolone; Rabbits; Rats; Vasoconstrictor Agents | 1980 |
Effect of halopredone acetate on rat liver tryptophan oxygenase and tyrosine aminotransferase activities.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Body Weight; Fluocinolone Acetonide; Gossypium; Hydrocortisone; Inflammation; Injections, Intravenous; Injections, Subcutaneous; Liver; Male; Pregnadienes; Rats; Time Factors; Tryptophan Oxygenase; Tyrosine Transaminase | 1977 |
Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
Topics: Administration, Topical; Animals; Betamethasone Valerate; Dexamethasone; Fluocinolone Acetonide; Fluocinonide; Inflammation; Male; Rats; Thymus Gland; Triamcinolone Acetonide | 1976 |
Quantitative effect of topically applied anti-inflammatory agents on external ocular inflammation in rats.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Croton Oil; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Eye Diseases; Female; Fluocinolone Acetonide; Hydrocortisone; Inflammation; Irritants; Rats; Time Factors; Triamcinolone; Triamcinolone Acetonide | 1973 |
Accidental irradiation of skin on hands with a proton beam of 4 MeV energy.
Topics: Animals; Chromosomes; Female; Fingers; Fluocinolone Acetonide; Hand Injuries; Humans; Inflammation; Lymphocytes; Protons; Radiation Dosage; Radiodermatitis; Regional Blood Flow; Skin | 1973 |
Inhibition of prostaglandin biosynthesis by corticosteroids.
Topics: Animals; Arachidonic Acids; Chromatography, Thin Layer; Female; Fluocinolone Acetonide; Hydrocortisone; In Vitro Techniques; Inflammation; Prostaglandins; Rats; Skin | 1972 |
The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Cell Membrane Permeability; Exudates and Transudates; Fluocinolone Acetonide; Glucocorticoids; Hydrocortisone; Inflammation; Leukocytes; Male; Methylcellulose; Prednisolone; Rats; Triamcinolone Acetonide | 1969 |